{'fraction_non_alphanumeric': 0.020242914979757085, 'fraction_numerical': 0.0, 'mean_word_length': 6.203883495145631, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Stepped treatment: Stimulants may be adequate to treat comorbid aggression

The first‐line treatment for attention‐deficit hyperactivity disorder (ADHD) is pharmacotherapy with stimulants, but children with coexisting aggressive behavior receive additional medications despite lack of evidence for the benefits of these adjuncts. Furthermore, the adverse effects of some of the adjuncts are well‐established. So, researchers looked at the comparison of stimulant monotherapy, risperidone, and divalproex sodium in reducing aggressive behavior in children with ADHD whose aggression persisted after the stimulant monotherapy was optimized. The monotherapy was judged by giving the children a placebo in this small randomized controlled trial.